PD-1 MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Siena, S; Elez, E; Peeters, M; André, T; Van den Eynde, M; Ng, K; Cercek, A; Fountzilas, C; Sanchez, F; Hubbard, J; Wu, C; Tabernero, J; Kardosh, A; Saeed, A; Strickler, J; Bekaii-Saab, T; Stecher, M; Palanca-Wessels, M; Van Cutsem, E

Published Date

  • July 2021

Published In

Volume / Issue

  • 32 /

Start / End Page

  • S199 - S199

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2021.05.019